These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38697115)

  • 1. Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells.
    Motte J; Sgodzai M; Schneider-Gold C; Steckel N; Mika T; Hegelmaier T; Borie D; Haghikia A; Mougiakakos D; Schroers R; Gold R
    Neuron; 2024 Jun; 112(11):1757-1763.e2. PubMed ID: 38697115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
    Bodkin C; Pascuzzi RM
    Neurol Clin; 2021 Feb; 39(1):133-146. PubMed ID: 33223079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis Lambert-Eaton overlap syndrome.
    Oh SJ
    Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
    Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
    Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunopathogenesis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Lisý L
    Bratisl Lek Listy; 1997 Apr; 98(4):217-20. PubMed ID: 9264830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
    Eymard B
    Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Sanders DB; Guptill JT
    Continuum (Minneap Minn); 2014 Oct; 20(5 Peripheral Nervous System Disorders):1413-25. PubMed ID: 25299290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.
    Newsom-Davis J; Leys K; Vincent A; Ferguson I; Modi G; Mills K
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):452-3. PubMed ID: 1650816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome.
    Faissner S; Motte J; Sgodzai M; Geis C; Haghikia A; Mougiakakos D; Borie D; Schroers R; Gold R
    Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2403227121. PubMed ID: 38885382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Maddison P; McConville J; Farrugia ME; Davies N; Rose M; Norwood F; Jungbluth H; Robb S; Hilton-Jones D
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):671-3. PubMed ID: 20392977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Miralles F
    Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-Diaminopyridine for the treatment of myasthenia gravis with electrophysiological patterns of Lambert-Eaton myasthenic syndrome.
    Lee MK; Sunwoo IN; Kim SM
    J Clin Neurosci; 2018 Apr; 50():194-198. PubMed ID: 29402568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.
    Fischbach F; Richter J; Pfeffer LK; Fehse B; Berger SC; Reinhardt S; Kuhle J; Badbaran A; Rathje K; Gagelmann N; Borie D; Seibel J; Ayuk F; Friese MA; Heesen C; Kröger N
    Med; 2024 Jun; 5(6):550-558.e2. PubMed ID: 38554710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis Lambert-Eaton overlap syndrome: Recommended modification for the diagnostic criteria.
    Oh SJ
    Muscle Nerve; 2024 Oct; 70(4):731-732. PubMed ID: 39072842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Triple-Negative Myasthenia Gravis Lambert-Eaton Overlap Syndrome With Negative Agrin and LRP-4 Antibodies.
    Maturana MA; Bertorini TE; Mei L; Pandhi A; Mays WH
    J Clin Neuromuscul Dis; 2019 Dec; 21(2):103-106. PubMed ID: 31743253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.